Aadel A. Chaudhuri

Mayo Clinic — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index10.1kcitations332works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(135), Lung Cancer Treatments and Mutations(79), Radiomics and Machine Learning in Medical Imaging(43), Prostate Cancer Treatment and Research(41), Lung Cancer Diagnosis and Treatment(38)

Publications332 total

Cognitive bias in LLM reasoning compromises interpretation of clinical oncology notes
arXiv (Cornell University)·2025Open Access
Liquid biopsy for very early detection of HPV-associated oropharyngeal cancer
JNCI Journal of the National Cancer Institute·2025Open Access
Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Clinical Cancer Research·2025Open Access
Enrichment of Brain Tumor-Derived ctDNAs and MicroRNAs in Blood Circulation in Patients Using Sonobiopsy
The Journal of Liquid Biopsy·2025Open Access
Improved reconstruction of single-cell developmental potential with CytoTRACE 2
Nature Methods·2025· 19 citedOpen Access
MA03.05 Circulating Tumor DNA Tumor Fraction as a Precision Biomarker for Radiotherapy in Oligometastatic NSCLC
Journal of Thoracic Oncology·2025· 1 cited
Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization
Nature reviews. Cancer·2025· 1 cited
Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC
JTO Clinical and Research Reports·2025Open Access
Data from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025Open Access
Figures S1-S8 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025Open Access
Table S1-S10 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025Open Access
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Annals of Translational Medicine·2025Open Access
A molecular biomarker for longitudinal monitoring of therapeutic efficacy in a real-world cohort of advanced solid tumors treated with immune checkpoint inhibitors.
Journal of Clinical Oncology·2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
Cancer Discovery·2025· 10 citedOpen Access
Abstract 1946: Postoperative lymphatic exudate in HPV-negative head and neck cancer detects recurrence prior to adjuvant treatment decisions
Cancer Research·2025
Abstract 3258: Predicting genitourinary cancer tissue-of-origin using urine cell-free DNA fragmentomics and cell-free RNA
Cancer Research·2025
Current and future directions in theranostics for neuroendocrine prostate cancer
Cancer Treatment Reviews·2025· 8 cited
IP14-01 GENOME-WIDE FRAGMENTOMICS AND COPY NUMBER PROFILING OF URINE CFDNA PREDICTS TUMOR ORIGIN IN GENITOURINARY CANCERS
The Journal of Urology·2025
Plasma-First Testing in Advanced Lung Cancer: Evidence and Implications
Journal of Thoracic Oncology·2025
Implementation of a Multicancer Detection (MCD) Test in a Tertiary Referral Center in Asymptomatic Patients: An 18-Month Prospective Cohort Study
Journal of Primary Care & Community Health·2025· 5 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Peter K. Harris(12), Maximilian Diehn(11), Ryan M. O’Connell(10), David Baltimore(10), Jeffrey J. Szymanski(9), Dinesh S. Rao(8), Ash A. Alizadeh(8), Noah Earland(8), Jacob J. Chabon(7), Henning Stehr(7), Aaron M. Newman(7), Faridi Qaium(7), Barzin Y. Nabet(6), Billy W. Loo(6), Abul Usmani(6), Pradeep S. Chauhan(6), Wenjia Feng(6), Bruna Pellini(6), Mohammad Shahrokh Esfahani(5), Chih Long Liu(5)